U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Morbidity and Mortality Weekly Report (MMWR)

CDC Stacks Public Health Publications

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

(57)
(67)
(184)
(230)
(500)
(673)
(659)
(403)
(489)
(557)
(246)
(325)
(427)
(406)
(97)
(156)
(103)
(110)
(97)
(92)
(119)
(92)
(108)
(96)
(97)
(92)
(79)
(97)
(87)
(91)
(88)
(76)
(74)
(84)
(80)
(69)
(70)
(73)
(68)
(69)
(59)
(67)
(62)
(64)
(62)
(66)
(72)
(55)
(53)
(55)
(60)
(56)
(58)
(54)
(53)
(56)
(55)
(52)
(54)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(51)
0 of 75
(56)
(63)
(187)
(223)
(500)
(663)
(656)
(409)
(483)
(558)
(231)
(311)
(436)
(413)
(91)
(148)
(100)
(104)
(102)
(92)
(120)
(92)
(104)
(97)
(97)
(91)
(80)
(97)
(86)
(90)
(87)
(76)
(75)
(84)
(80)
(69)
(69)
(71)
(69)
(64)
(60)
(68)
(62)
(62)
(62)
(67)
(72)
(56)
(55)
(54)
(59)
(57)
(58)
(54)
(53)
(55)
(55)
(55)
(53)
(53)
(53)
(53)
(54)
(53)
(53)
(53)
(53)
(53)
(54)
(54)
(53)
(53)
(53)
(53)
(54)
0 of 75
(1)
(7)
(33)
(71)
(44)
(137)
(157)
(161)
(151)
(137)
(163)
(169)
(155)
(160)
(161)
(157)
(164)
(165)
(157)
(165)
(157)
(174)
(142)
(156)
(159)
(135)
(156)
(141)
(142)
(141)
(137)
(138)
(142)
(131)
(162)
(144)
(136)
(152)
(152)
(177)
(206)
(197)
(165)
(187)
(179)
(201)
(205)
(202)
(223)
(226)
(232)
(221)
(225)
(252)
(252)
(278)
0 of 56
(2)
(1)
(4)
(431)
(108)
(406)
(13)
(8559)
0 of 8
(16)
(34)
(2)
(6)
(39)
(4)
(1)
(1)
0 of 8
(10)
(18)
(10)
(9)
(11)
(10)
(25)
(11)
(7)
(27)
(21)
(42)
(7)
(58)
(7)
(23)
(13)
(38)
(10)
(10)
(50)
(8)
(1237)
(23)
(1293)
(32)
(71)
(91)
(27)
(16)
(7)
(128)
(70)
(790)
(24)
(198)
(39)
(61)
(38)
(19)
(26)
(20)
(15)
(26)
(9)
(11)
(17)
(10)
(7)
(49)
(11)
(8)
(224)
(17)
(17)
(8)
(181)
(137)
(130)
(33)
(8)
(15)
(13)
(9)
(10)
(13)
(15)
(9)
(15)
(8)
(30)
(18)
(10)
(7)
(18)
(99)
(13)
(12)
(36)
(8)
(18)
(12)
(7)
(13)
(11)
(30)
(10)
(28)
(9)
(9)
(15)
(21)
(8)
(17)
(7)
(8)
(31)
(77)
(60)
(8)
(7)
(14)
(12)
(13)
(15)
(19)
(11)
(85)
(13)
(14)
(31)
(13)
(30)
(14)
(12)
(187)
(7)
(7)
(17)
(8)
(18)
(53)
(11)
(10)
(8)
(24)
(21)
(691)
(8)
(11)
(15)
(59)
(205)
(7)
(9)
(18)
(10)
(66)
(14)
(23)
(7)
(17)
(22)
(21)
(7)
(15)
(10)
(9)
(24)
(13)
(31)
(20)
(7)
(13)
(29)
(13)
(31)
(74)
(26)
(20)
(7)
(7)
(8)
(13)
(28)
(25)
(9)
(941)
(9)
(14)
(14)
(740)
(35)
(103)
(10)
(51)
(10)
(20)
(11)
(11)
(9)
(58)
(12)
(20)
(14)
(49)
(20)
(21)
(19)
(20)
(16)
(177)
(81)
(2981)
(316)
(263)
(12)
(543)
(215)
(37)
(38)
(25)
(14)
(15)
(14)
(12)
(34)
(10)
(80)
(14)
(11)
(8)
(23)
(8)
(8)
(439)
(23)
(15)
(8)
(73)
(19)
(28)
(31)
(24)
(10)
(18)
(18)
(18)
(45)
(74)
(8)
(40)
(11)
(8)
(11)
(20)
(19)
(58)
(9)
(23)
(8)
(16)
(34)
(44)
(83)
(9)
(10)
(9)
(21)
(65)
(13)
(14)
(28)
(25)
(14)
(10)
(10)
(8)
(166)
(26)
(11)
(14)
(35)
(24)
(9)
(9)
(24)
(26)
(12)
(92)
(4171)
(642)
(34)
(12)
(17)
(14)
(11)
(10)
(12)
(13)
(9)
(28)
(16)
(19)
(8)
(12)
(27)
(17)
(46)
(20)
(28)
(36)
(10)
(20)
(21)
(8)
(8)
(8)
(66)
(91)
(9)
(25)
(27)
(13)
(21)
(22)
(8)
(39)
(56)
(69)
(21)
(15)
(149)
(16)
(14)
(8)
(12)
(32)
(19)
(19)
(16)
(22)
(10)
(11)
(144)
(45)
(32)
(9)
(41)
(15)
(32)
(660)
(26)
(9)
(56)
(14)
(130)
(9)
(18)
(62)
(10)
(10)
(30)
(11)
(10)
(13)
(21)
(8)
(15)
(23)
(111)
(23)
(1338)
(15)
(10)
(17)
(11)
(13)
(8)
(8)
(48)
(8)
(42)
(45)
(25)
(47)
(13)
(25)
(186)
(14)
(16)
(11)
(586)
(394)
(15)
(21)
(14)
(152)
(16)
(53)
(9)
(28)
(10)
(19)
(162)
(8)
(10)
(14)
(31)
(9)
(8)
(9)
(19)
(11)
(8)
(8)
(110)
(10)
(78)
(11)
(68)
(60)
(17)
(23)
(60)
(132)
(19)
(105)
(58)
(12)
(39)
(126)
(35)
(97)
(52)
(17)
(10)
(11)
(12)
(12)
(8)
(14)
(52)
(71)
(116)
(173)
(25)
(17)
(50)
(13)
(10)
(33)
(12)
(10)
(46)
(8)
(29)
(11)
(8)
(8)
(60)
(31)
(90)
(44)
(12)
(28)
(51)
(9)
(207)
(18)
(32)
(17)
(19)
(2446)
(16)
(19)
(18)
(11)
(106)
(8)
(207)
(232)
(20)
(38)
(23)
(8)
(8)
(9)
(18)
(240)
(11)
(49)
(678)
(47)
(10)
(308)
(15)
(63)
(23)
(17)
(8)
(21)
(188)
(54)
(48)
(8)
(45)
(114)
(50)
(125)
(28)
(11)
(10)
(596)
(15)
(22)
(13)
(61)
(9)
(26)
(29)
(14)
(37)
(12)
(8)
(32)
(12)
(22)
(8)
(8)
(22)
(13)
(16)
(11)
(10)
(73)
(9)
(10)
(10)
(74)
(32)
(114)
(9)
(13)
(41)
(17)
(55)
(17)
(13)
(16)
(18)
(10)
(17)
(44)
(66)
(10)
(11)
(9)
(10)
(12)
(177)
(12)
(14)
(17)
(1181)
(9)
(9)
(8)
(50)
(10)
(44)
(109)
(10)
(16)
(8)
(19)
(312)
(33)
(23)
(12)
(9)
(84)
(11)
(12)
(41)
(11)
(18)
(20)
(8)
(11)
(8)
(8)
(19)
(58)
(32)
(82)
(14)
(37)
(8)
(21)
(40)
(13)
(17)
(17)
(9)
(9)
(66)
(19)
(963)
(103)
(15)
(48)
(30)
(8)
(11)
(57)
(3831)
(11)
(9)
(9)
(29)
(8)
(22)
(16)
(16)
(15)
(17)
(10)
(8)
(13)
(8)
(11)
(18)
(9)
(14)
(15)
(9)
(16)
(41)
(43)
(20)
(10)
(27)
(11)
(12)
(10)
(15)
(243)
(18)
(22)
(36)
(8)
(15)
(113)
(10)
(257)
(611)
(72)
(11)
(23)
(17)
(8)
(11)
(15)
(9)
(10)
(10)
(301)
(12)
(11)
(8)
(14)
(12)
(11)
(20)
(10)
(10)
(16)
(13)
(13)
(22)
(10)
(10)
(65)
(10)
(9)
(10)
(9)
(19)
(12)
(9)
(144)
(18)
(15)
(8)
(33)
(144)
(22)
(11)
(171)
(10)
(8)
(8)
(70)
(30)
(25)
(21)
(343)
(24)
(115)
(36)
(11)
(8)
(84)
(34)
(14)
(8)
(10)
(21)
(29)
(20)
(16)
(1141)
(18)
(27)
(18)
(22)
(110)
(15)
(22)
(23)
(349)
(19)
(72)
(16)
(26)
(14)
(15)
(10)
(26)
(35)
(10)
(9)
(11)
(216)
(50)
(16)
(23)
(34)
(21)
(10)
(19)
(74)
(20)
(9)
(233)
(1005)
(22)
(24)
(71)
(101)
(2519)
(11)
(104)
(12)
(23)
(15)
(16)
(14)
(93)
(177)
(38)
(14)
(11)
(279)
(15)
(9)
(13)
(45)
(8)
(32)
(91)
(9)
(17)
(18)
(11)
(23)
(71)
(37)
(18)
(12)
(8)
(12)
(21)
(10)
(28)
(10)
(10)
(8)
(24)
(104)
(187)
(28)
(29)
(25)
(10)
(20)
(9)
(58)
(195)
(303)
(67)
(8)
(21)
(12)
(8)
(59)
(18)
(34)
(9)
(38)
(177)
(10)
(617)
(31)
(32)
(146)
(241)
(12)
(18)
(10)
(8)
(122)
(11)
(126)
(9)
(16)
(18)
(15)
(20)
(11)
(9)
(19)
(11)
(28)
(35)
(37)
(11)
(8)
(65)
(22)
(42)
(14)
(16)
(28)
(10)
(10)
(14)
(12)
(80)
(31)
(8)
(39)
(9)
(20)
(18)
(12)
(184)
(28)
(9)
(23)
(71)
(25)
(23)
(25)
(14)
(8)
(9)
(108)
(8)
(22)
(16)
(44)
(16)
(134)
(51)
(10)
(19)
(10)
(56)
(10)
(8)
(12)
(18)
(94)
(31)
(35)
(12)
(49)
(8)
(38)
(91)
(9)
(22)
(14)
(183)
(8)
(11)
(8)
(19)
(33)
(21)
(19)
(12)
(8)
(69)
(9)
(54)
(15)
(12)
(8)
(15)
(8)
(8)
(10)
(58)
(19)
(182)
(28)
(36)
(22)
(106)
(19)
(157)
(9)
(12)
(15)
(13)
(68)
(9)
(14)
(182)
(10)
(10)
(19)
(62)
(13)
(29)
(17)
(50)
(17)
(19)
(9)
(14)
(466)
(48)
(50)
(105)
(11)
(17)
(104)
(8)
(29)
(24)
(34)
(21)
(40)
(10)
(23)
(31)
(20)
(35)
(21)
(18)
(12)
(8)
(43)
(94)
(22)
(26)
(9)
(23)
(9)
(12)
(8)
(39)
(14)
(14)
(59)
(11)
(9)
(38)
(17)
(16)
(39)
(16)
(78)
(8)
(43)
(13)
(15)
(10)
(46)
(27)
(762)
(30)
(57)
(10)
(12)
(29)
(33)
(10)
(10)
(8)
(14)
(51)
(8)
(61)
(16)
(9)
0 of 1000
(12)
(12)
(15)
(7)
(23)
(9)
(7)
(18)
(8)
(7)
(10)
(11)
(7)
(9)
(7)
(10)
(9)
(11)
(11)
(19)
(9)
(11)
(9)
(10)
(27)
(8)
(9)
(12)
(23)
(15)
(9)
(7)
(7)
(7)
(9)
(13)
(11)
(9)
(15)
(7)
(7)
(7)
(7)
(9)
(8)
(19)
(9)
(9)
(7)
(7)
(13)
(7)
(7)
(9)
(7)
(9)
(7)
(16)
(13)
(7)
(12)
(12)
(22)
(28)
(15)
(8)
(8)
(13)
(7)
(19)
(12)
(12)
(13)
(15)
(16)
(9)
(10)
(7)
(11)
(28)
(7)
(13)
(28)
(7)
(10)
(11)
(11)
(13)
(10)
(8)
(18)
(9)
(10)
(16)
(29)
(8)
(12)
(12)
(13)
(8)
(9)
(7)
(28)
(9)
(16)
(7)
(29)
(7)
(8)
(8)
(11)
(16)
(16)
(12)
(35)
(8)
(11)
(16)
(18)
(9)
(29)
(9)
(14)
(22)
(31)
(11)
(7)
(7)
(10)
(7)
(18)
(9)
(7)
(9)
(7)
(7)
(7)
(11)
(9)
(23)
(20)
(10)
(7)
(7)
(15)
(10)
(8)
(37)
(8)
(22)
(10)
(16)
(11)
(10)
(24)
(13)
(7)
(11)
(7)
(9)
(11)
(9)
(12)
(21)
(9)
(9)
(7)
(11)
(7)
(16)
(9)
(7)
(9)
(12)
(19)
(13)
(7)
(7)
(7)
(11)
(10)
(7)
(9)
(24)
(7)
(8)
(10)
(12)
(8)
(13)
(25)
(23)
(7)
(24)
(16)
(9)
(7)
(10)
(9)
(8)
(8)
(13)
(9)
(9)
(10)
(7)
(10)
(7)
(20)
(8)
(9)
(7)
(18)
(17)
(11)
(10)
(12)
(9)
(12)
(7)
(9)
(7)
(9)
(18)
(8)
(12)
(8)
(8)
(8)
(13)
(7)
(7)
(8)
(15)
(7)
(17)
(17)
(16)
(8)
(20)
(7)
(8)
(11)
(11)
(21)
(8)
(11)
(10)
(13)
(9)
(8)
(7)
(12)
(8)
(15)
(9)
(11)
(7)
(15)
(12)
(17)
(16)
(7)
(18)
(24)
(11)
(7)
(7)
(12)
(8)
(19)
(20)
(16)
(11)
(12)
(7)
(8)
(10)
(14)
(16)
(7)
(9)
(11)
(20)
(15)
(9)
(16)
(48)
(9)
(11)
(24)
(11)
(8)
(9)
(7)
(10)
(9)
(7)
(10)
(8)
(53)
(13)
(9)
(11)
(15)
(42)
(16)
(8)
(8)
(29)
(10)
(7)
(10)
(8)
(8)
(24)
(8)
(11)
(12)
(8)
(13)
(21)
(24)
(10)
(10)
(16)
(20)
(11)
(10)
(15)
(17)
(12)
(18)
(7)
(17)
(16)
(10)
(15)
(18)
(14)
(16)
(22)
(7)
(9)
(17)
(12)
(15)
(8)
(18)
(20)
(15)
(11)
(29)
(7)
(10)
(23)
(7)
(7)
(27)
(8)
(7)
(26)
(18)
(8)
(12)
(11)
(8)
(36)
(15)
(12)
(7)
(8)
(15)
(16)
(7)
(7)
(9)
(10)
(9)
(17)
(7)
(12)
(12)
(13)
(12)
(16)
(9)
(13)
(8)
(15)
(24)
(8)
(8)
(8)
(7)
(17)
(9)
(7)
(28)
(12)
(15)
(13)
(9)
(7)
(7)
(9)
(8)
(7)
(8)
(14)
(9)
(14)
(17)
(7)
(8)
(7)
(10)
(11)
(7)
(16)
(9)
(59)
(12)
(8)
(8)
(7)
(7)
(9)
(7)
(18)
(7)
(8)
(18)
(9)
(15)
(10)
(8)
(25)
(11)
(8)
(9)
(14)
(26)
(23)
(8)
(43)
(11)
(14)
(7)
(15)
(11)
(20)
(7)
(28)
(15)
(10)
(9)
(26)
(18)
(7)
(8)
(8)
(7)
(18)
(15)
(15)
(11)
(7)
(8)
(7)
(10)
(14)
(8)
(30)
(15)
(7)
(9)
(19)
(18)
(15)
(9)
(7)
(7)
(8)
(13)
(11)
(15)
(17)
(8)
(49)
(7)
(32)
(13)
(10)
(16)
(7)
(23)
(24)
(9)
(10)
(25)
(8)
(20)
(7)
(7)
(13)
(7)
(11)
(9)
(7)
(7)
(10)
(9)
(8)
(9)
(7)
(7)
(10)
(16)
(14)
(12)
(7)
(10)
(7)
(20)
(9)
(15)
(7)
(11)
(12)
(11)
(13)
(8)
(7)
(19)
(26)
(17)
(7)
(15)
(9)
(8)
(18)
(17)
(8)
(8)
(12)
(7)
(10)
(7)
(9)
(8)
(18)
(18)
(11)
(8)
(35)
(21)
(7)
(7)
(18)
(9)
(7)
(10)
(7)
(10)
(9)
(14)
(14)
(10)
(24)
(12)
(8)
(53)
(7)
(7)
(19)
(8)
(10)
(7)
(10)
(8)
(11)
(7)
(9)
(8)
(8)
(20)
(13)
(27)
(8)
(8)
(19)
(7)
(19)
(7)
(11)
(7)
(12)
(7)
(11)
(11)
(28)
(10)
(9)
(7)
(20)
(10)
(13)
(7)
(8)
(9)
(13)
(11)
(10)
(7)
(13)
(9)
(7)
(10)
(8)
(7)
(7)
(10)
(14)
(9)
(38)
(23)
(10)
(8)
(7)
(10)
(11)
(10)
(13)
(15)
(10)
(7)
(17)
(10)
(7)
(7)
(11)
(11)
(12)
(8)
(10)
(18)
(14)
(8)
(10)
(21)
(16)
(14)
(14)
(9)
(15)
(9)
(19)
(24)
(11)
(20)
(21)
(16)
(7)
(7)
(10)
(23)
(7)
(8)
(17)
(7)
(9)
(10)
(7)
(7)
(17)
(8)
(8)
(7)
(9)
(9)
(13)
(10)
(8)
(13)
(9)
(13)
(8)
(18)
(7)
(7)
(27)
(12)
(8)
(15)
(9)
(17)
(8)
(18)
(7)
(26)
(12)
(9)
(9)
(19)
(10)
(7)
(7)
(13)
(7)
(7)
(8)
(10)
(21)
(15)
(35)
(14)
(18)
(7)
(7)
(7)
(8)
(21)
(16)
(24)
(24)
(18)
(8)
(7)
(18)
(12)
(7)
(7)
(13)
(25)
(7)
(8)
(12)
(11)
(19)
(7)
(27)
(18)
(10)
(10)
(8)
(12)
(7)
(7)
(7)
(10)
(7)
(7)
(10)
(16)
(12)
(10)
(7)
(18)
(7)
(25)
(10)
(15)
(10)
(18)
(24)
(13)
(16)
(9)
(19)
(13)
(26)
(16)
(18)
(8)
(10)
(8)
(10)
(14)
(7)
(10)
(7)
(13)
(7)
(7)
(11)
(17)
(7)
(15)
(13)
(13)
(13)
(8)
(33)
(8)
(11)
(11)
(8)
(11)
(12)
(21)
(10)
(9)
(12)
(23)
(8)
(11)
(14)
(8)
(19)
(11)
(8)
(8)
(11)
(9)
(8)
(11)
(10)
(8)
(8)
(14)
(13)
(10)
(16)
(9)
(30)
(11)
(11)
(10)
(14)
(23)
(8)
(9)
(12)
(11)
(10)
(8)
(8)
(9)
(20)
(17)
(12)
(10)
(8)
(18)
(13)
(17)
(11)
(9)
(29)
(10)
(9)
(13)
(11)
(8)
(29)
(13)
(13)
(9)
(11)
(40)
(8)
(10)
(12)
(14)
(8)
(13)
(16)
(9)
(12)
(8)
(9)
(11)
(8)
(9)
(40)
(10)
(9)
(20)
(17)
(8)
(24)
(13)
(10)
(24)
(9)
(18)
(20)
(9)
(9)
(8)
(8)
(29)
(15)
(8)
(73)
(9)
(38)
(8)
(23)
(10)
(24)
(9)
(12)
(9)
(8)
(10)
(12)
(11)
(8)
(22)
(9)
(13)
(10)
(16)
(8)
(9)
(13)
(17)
(11)
(8)
(12)
(15)
(9)
(9)
(13)
(9)
(8)
(20)
(14)
(33)
(9)
(16)
(10)
(10)
(10)
(12)
(8)
(9)
(33)
(16)
(8)
(10)
(8)
(11)
(13)
(14)
(21)
(10)
(15)
(8)
(8)
(12)
(8)
(15)
(12)
(18)
(9)
(12)
(13)
(13)
(23)
(11)
(15)
(12)
(9)
(8)
(8)
(13)
(25)
(13)
(17)
(8)
(13)
(11)
(13)
(11)
(9)
(10)
(8)
(10)
(21)
(13)
(21)
(23)
(25)
(8)
(9)
(11)
(11)
(15)
(10)
(13)
(10)
(9)
(19)
(14)
(10)
(15)
(28)
0 of 1000
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(4)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(9)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(3)
(2)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(16)
(1)
(1)
(14)
(7)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(33)
(1)
(2)
(106)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(13)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(2)
(68)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(8)
(1)
(4)
(3)
(5)
(6)
(2)
(1)
(11)
(1)
(2)
(3)
(1)
(4)
(7)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(12)
(1)
(3)
(1)
(3)
(1)
(1)
(125)
(1)
(2)
(1)
(1)
(4)
(22)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3943)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(3)
(1)
(3)
(1)
(1)
(1)
(2)
(11)
(10)
(1)
(1)
(41)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(14)
(1)
(1)
(4)
(20)
(1)
(7)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(13)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(7)
(2)
(1)
(1)
(2)
(1)
(65)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(6)
(5)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(33)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(3)
(21)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(425)
(1)
(1)
(1)
(2)
(1)
(1)
(5)
(1)
(3)
(1)
(1)
(6)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(3)
(5)
(2)
(2)
(2)
(4)
(3)
(3)
(4)
(2)
(2)
(2)
(3)
(3)
(9)
(2)
(2)
(2)
(2)
(2)
(9)
(7)
(4)
(2)
(2)
(5)
(2)
(12)
(2)
(7)
(12)
(4)
(2)
(3)
(4)
(2)
(3)
(4)
(2)
(5)
(4)
(7)
(2)
(5)
(7)
(2)
(9)
(4)
(2)
(4)
(9)
(2)
(2)
(2)
(2)
(4)
(2)
(8)
(9)
(3)
(3)
(2)
(2)
(5)
(2)
(5)
(4)
(3)
(2)
(9)
(4)
(4)
(3)
(6)
(4)
(2)
(3)
(2)
(6)
(2)
(2)
(11)
(3)
(2)
(2)
(2)
(3)
(2)
(10)
(2)
(4)
(8)
(2)
(15)
(2)
(2)
(3)
(20)
(6)
(2)
(2)
(5)
(2)
(13)
(11)
(2)
(24)
(2)
(3)
(3)
(7)
(2)
(3)
(3)
(3)
(2)
(9)
(2)
(14)
(2)
(7)
(3)
(4)
(3)
(2)
(3)
(9)
(5)
(9)
(50)
(8)
(3)
(13)
(3)
(3)
(2)
(4)
(3)
(9)
(5)
(2)
(2)
(3)
(2)
(15)
(9)
(5)
(4)
(2)
(5)
(4)
(5)
(4)
(5)
(5)
(11)
(4)
(12)
(5)
(2)
(2)
(7)
(5)
(3)
(3)
(2)
(5)
(2)
(2)
(2)
(3)
(2)
(3)
(2)
(7)
(2)
(2)
(3)
(3)
(3)
(6)
(2)
(3)
(3)
(10)
(2)
(16)
(2)
(7)
(9)
(6)
(4)
(7)
(5)
(4)
(11)
(3)
(4)
(13)
(17)
(2)
(2)
(149)
(24)
(2)
(2)
(4)
(8)
(7)
(11)
(8)
(5)
(3)
(13)
(4)
(17)
(6)
(9)
(2)
(22)
(2)
(2)
(6)
(3)
(9)
(4)
(2)
(3)
(15)
(3)
(4)
(3)
(6)
(8)
(15)
(2)
(23)
(2)
(2)
(4)
(5)
(5)
(24)
(2)
(4)
(2)
(7)
(2)
(2)
(9)
(3)
(2)
(9)
(6)
(11)
(5)
(15)
(4)
(2)
(3)
(5)
(6)
(2)
(118)
(5)
(18)
(3)
(2)
(7)
(125)
(2)
(3)
(2)
(5)
(7)
(2)
(3)
(2)
(4)
(6)
(3)
(3)
(2)
(3)
(2)
(6)
(10)
(12)
(2)
(3)
(3)
(4)
(4)
(9)
(2)
(2)
(2)
(5)
(6)
(4)
(2)
(2)
(2)
(2)
(2)
(4)
(13)
(4)
(2)
(3)
(2)
(9)
(4)
(2)
(2)
(2)
(7)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(4)
(3)
(3)
(3)
(4)
(2)
(12)
(4)
(2)
(5)
(6)
(5)
(2)
(3)
(14)
(4)
(2)
(2)
(2)
(2)
(14)
(7)
(2)
(2)
(3)
(3)
(2)
(2)
(7)
(44)
(183)
(2)
(88)
(115)
(2)
(8)
(2)
(3)
(26)
(80)
(2)
(2)
(22)
(3)
(2)
(36)
(30)
(10)
(8)
(16)
(10)
(5)
(2)
(14)
(180)
(2)
(3)
(3)
(2)
(93)
(6)
(2)
(2)
(4)
(317)
(7)
(11)
(2)
(6)
(4)
(3)
(3)
(6)
(2)
(4)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(3)
(2)
(2)
(2)
(2)
(3)
(2)
(5)
(4)
(2)
(2)
(2)
(2)
(4)
(4)
(2)
(3)
(15)
(3)
(2)
(2)
(14)
(2)
(5)
(2)
(6)
(15)
(13)
(4)
(2)
(3)
(5)
(2)
(8)
(2)
(4)
(2)
(2)
(3)
(3)
(7)
(4)
(2)
(2)
(4)
(2)
(2)
(4)
(2)
(2)
(2)
0 of 1000
(2)
(1)
(111)
(8)
(1)
(2855)
(2004)
(4)
(13)
(34)
(81)
(3)
(1)
(1)
(2)
(3)
(19)
(1)
(46)
(4166)
(2)
(4)
(2)
0 of 23
(1)
(15)
(33)
(8)
(13)
(1)
(8)
(2)
(2)
(4)
(5)
(25)
(1)
(2)
(180)
(1)
(114)
(2)
(3)
(7)
(1)
(3)
(10)
(11)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(168)
(159)
(1)
(1)
(1)
(1)
(20)
(1)
(28)
(1)
(1)
(2)
(1)
(23)
(2)
(1)
(1)
(1)
(1)
(23)
(8)
(1)
(2)
(3)
(1)
(6)
(1)
(19)
(1)
(7)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(3)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(12)
(1)
(1)
(1)
(2)
(1)
(1)
(16)
(1)
(3)
(1)
(20)
(1)
(5)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(4)
(1)
(2)
(2)
(2)
(1)
(871)
(2)
(1)
(11)
(1)
(3)
(6)
(1)
(1)
(1)
(87)
(4)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(3)
(2)
(1)
(14)
(3)
(4)
(53)
(1)
(1)
(1)
(1)
(8)
(17)
(1)
(1)
(1)
(1)
(7)
(1)
(8)
(266)
(1)
(7)
(1)
(1)
(3)
(201)
(2)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(2)
(39)
(1)
(1)
(17)
(13)
(1)
(5)
(1)
(2)
(11)
(1)
(1)
(177)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(4)
(1)
(7)
(1)
(4)
(1)
(1)
(68)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(39)
(2)
(1)
(1)
(5)
(3)
(12)
(316)
(1)
(1)
(1)
(1)
(28)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(468)
(3)
(6)
(42)
(1)
(3)
(12)
(5)
(4)
(10)
(1)
(1)
(20)
(1)
(8)
(1)
(1)
(1)
(3)
(2)
(15)
(14)
(8)
(2)
(18)
(1)
(112)
(1)
(1)
(1)
(1)
(4)
(5)
(24)
(1)
(1)
(9)
(1)
(3)
(76)
(307)
(1)
(1)
(1)
(31)
(161)
(12)
(1)
(174)
(3)
(3)
(10)
(7)
(25)
(1)
(1)
(1)
(4)
(23)
(42)
(1)
(1)
(1)
(1)
(111)
(1)
(1)
(1)
(1)
(213)
(18)
(1)
(1)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(7)
(4)
(1)
(1)
(1)
(1)
(4)
(32)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(13)
(3)
(1)
(4)
(5)
(96)
(1)
(2)
(209)
(1)
(3)
(2)
(2)
(3)
(1)
(1)
(127)
(9)
(7)
(3)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(204)
(1)
(1)
(272)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(55)
(1)
(1)
(1)
(1)
(1)
(5)
(265)
(12)
(5)
(3)
(11)
(1)
(8)
(1)
(3)
(1)
(1)
(3)
(1)
(306)
(1)
(131)
(1)
(163)
(1)
(1)
(1)
(77)
(4)
(3)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(3)
(3)
(112)
(1)
(1)
(9)
(2)
(27)
(34)
(1)
(1)
(3)
(18)
(60)
(1)
(237)
(2)
(1)
(187)
(2)
(1)
(5)
(1)
(500)
(6)
(1)
(7)
(1)
(1)
(156)
(5)
(1)
(16)
(2)
(1)
(6)
(3)
(2)
(1)
(1)
(3)
(3)
(5)
(9)
(4)
(31)
(1)
(1)
(4)
(1)
(248)
(45)
(4)
(1)
(1)
(2)
(1)
(10)
(8)
(5)
(2)
(1)
(1)
(1)
(57)
(72)
(80)
(241)
(256)
(318)
(52)
(45)
(51)
(88)
(1)
(1)
(1)
(1)
(1)
(558)
(114)
(1)
(1)
(4)
(10)
(1)
(1)
(267)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(7)
(8)
(31)
(8)
(7)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(301)
(1)
(1)
(13)
(10)
(2)
(1)
(27)
(1)
(1)
(1)
(1)
(18)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(19)
(1)
(1)
(1)
(5)
(16)
(1)
(2)
(1)
(154)
(1)
(1)
(1)
(5)
(1)
(9)
(1)
(1)
(3)
(2)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(11)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(3)
(1)
(4)
(1)
(4)
(1)
(1)
(1)
(8)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(18)
(13)
(1)
(14)
(1)
(1)
(13)
(11)
(1)
(2)
(1)
(117)
(46)
(4)
(8)
(2)
(1)
(9)
(4)
(20)
(1)
(2)
(2)
(1)
(5)
(2)
(1)
(2)
(1)
(14)
(1)
(1)
(1)
(1)
(2)
(2)
(22)
(24)
(1)
(1)
(1)
(3)
(1)
(18)
(1)
(1)
(10)
(1)
(1)
(1)
(1)
(1)
(185)
(1)
(1)
(481)
(22)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(11)
(8)
(1)
(1)
(1)
(7)
(1)
(1)
(130)
(1)
(11)
(27)
(1)
(1)
(1)
(67)
(7028)
(1)
(11)
(1)
(5)
(154)
(1)
(1)
(11)
(79)
(1)
(1)
(3)
(3)
(31)
(1)
(4)
(2)
(4)
(215)
(1)
(1)
(30)
(2)
(1)
(390)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(256)
(1)
(1)
(3)
(1)
(1)
(195)
(1)
(1)
(2)
(1)
(45)
(1)
(3)
(9)
(6)
(8)
(9)
(1)
(2)
(1)
0 of 775
(1)
(55)
(9)
(1)
(2)
(25)
(295)
(2)
(2)
(2)
(3)
(1)
(5)
(27)
(1)
(3)
(5)
(14)
(60)
(10)
(1)
(2)
(4)
(1)
(787)
(2802)
(3)
(5)
(5)
(37)
(1)
(16)
(1)
(7)
(3)
(16)
(3)
(27)
(1)
(108)
(2)
(383)
(51)
(1)
(1)
(1)
(1)
(2004)
(1)
(4)
(1)
(8)
(344)
(4)
(3)
(48)
(3)
0 of 57
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(8)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
0 of 794
(82)
(4)
(1)
(6)
0 of 4
Showing 941 - 960 of 9550 results
  • Effectiveness of 2dose BNT162b2 Pfizer BioNTech MRNA Vaccine in Preventing SARSCoV2 Infection Among Children Aged 511 Years and Adolescents Aged 1215 Years PROTECT Cohort July 2021February 2022
    Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
    Fowlkes, Ashley L. ;
    Yoon, Sarang K.
    March 11, 2022  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Receipt of 2 doses of Pfizer-BioNTech COVID-19 Vaccine has been shown to be effective in preventing infection with the SARS-CoV-2 B.1.617.2 (Delta) Variants in persons aged ≥12 years.What is added by this report? Children and adolescents aged 5–15 years were tested for SARS-CoV-2 weekly, irrespective of sympt ...
    Supporting Files Public Domain
  • Tobacco Product Use and Associated Factors Among Middle and High School Students National Youth Tobacco Survey United States 2021 3 Supplementary Tables
    Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021 [3 Supplementary Tables]
    National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health  ...
    2022/03/11 | Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
    Supplementary Table 1. Flavor Types Used Among Middle and High School Students Who Reported Current (Past 30-Day) Use of Flavored Tobacco Products, by Product - National Youth Tobacco Survey, United States, 2021Supplementary Table 2. E-Cigarette Device Types Reported Among Middle and High School Students Who Reported Current (Past 30-Day) Use* of E ...
    Public Domain
  • SARSCoV2 Incidence In MaskRequired K12 School Districts Compared with MaskOptional School Districts Arkansas AugustOctober 2021
    SARS-CoV-2 Incidence In Mask-Required K–12 School Districts Compared with Mask-Optional School Districts — Arkansas, August–October 2021
    Centers for Disease Control and Prevention (U.S.)
    03/08/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • SARSCoV2 Incidence in K12 School Districts with Maskrequired Versus Maskoptional Policies Arkansas AugustOctober 2021
    SARS-CoV-2 Incidence in K–12 School Districts with Mask-required Versus Mask-optional Policies — Arkansas, August–October 2021
    Donovan, Catherine V. ;
    Rose, Charles
    March 8, 2022  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Masks are an important part of a multicomponent Prevention strategy to limit Transmission of SARS-CoV-2. Some school jurisdictions required masks in K–12 schools for fall 2021, while others did not.What is added by this report? In Arkansas during August–October 2021, districts with universal mask requirements ...
    Supporting Files Public Domain
  • SARSCoV2 B11529 Omicron Variant Transmission Within Households Four US Jurisdictions November 2021February 2022
    SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
    Baker, Julia M. ;
    Nakayama, Jasmine Y.
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The B.1.1.529 (Omicron) Variants, first detected in November 2021, was responsible for a surge in U.S. infections with SARS-CoV-2, the Virus that causes COVID-19, during December 2021-January 2022 (1). To investigate the effectiveness of Prevention strategies in household settings, CDC partnered with four U.S. jurisdictions to describe Omicron hous ...
    Supporting Files Public Domain
  • QuickStats Percentage of Adults Aged 18 Years with Kidney Disease by Age Group and Sex National Health Interview Survey United States JulyDecember 2020
    QuickStats: Percentage of Adults Aged ≥18 Years with Kidney Disease, by Age Group and Sex — National Health Interview Survey, United States, July–December 2020
    Weeks, Julie D. ;
    Elgaddal, Nazik
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During July–December 2020, 3.1% of adults aged ≥18 years had kidney disease. The prevalence of kidney disease increased with age, from 1.1% among adults aged 18–44 years to 3.1% among those aged 45–64 years and to 7.1% among those aged ≥65 years. Among adults aged ≥65 years, a higher percentage of men had kidney disease (8.3%) compared with women ( ...
    Supporting Files Public Domain
  • Safety Monitoring of COVID19 Vaccine Booster Doses Among Persons Aged 1217 Years US December 9 2021February 20 2022
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — U.S. December 9, 2021–February 20, 2022
    Hause, Anne M. ;
    Baggs, James
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    As of February 20, 2022, only BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine has been authorized for use in persons aged 12-17 years in the U.S. (1). The Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for Pfizer-BioNTech vaccine on December 9, 2021, to authorize a homologous* booster dose for persons aged 16-17 years ...
    Supporting Files Public Domain
  • Geospatial Transmission Hotspots of Recent HIV Infection Malawi October 2019March 2020
    Geospatial Transmission Hotspots of Recent HIV Infection — Malawi, October 2019–March 2020
    Telford, Carson T. ;
    Tessema, Zaena
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Persons infected with HIV are more likely to transmit the Virus during the early stages (acute and recent) of infection, when viral load is elevated and opportunities to implement risk reduction are limited because persons are typically unaware of their status (1,2). Identifying recent HIV infections (acquired within the preceding 12 months)* is cr ...
    Supporting Files Public Domain
  • Notes From the Field Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating VaccineDerived Poliovirus Outbreak Tajikistan 20202021
    Notes From the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021
    O’Connor, Patrick ;
    Huseynov, Shahin
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Supporting Files Public Domain
  • Effectiveness of COVID19 PfizerBioNTech BNT162b2 mRNA Vaccination in Preventing COVID19Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 517 Years VISION Network 10 States April 2021January 2022
    Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
    Klein, Nicola P. ;
    Stockwell, Melissa S.
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    The efficacy of the BNT162b2 (Pfizer-BioNTech) vaccine against laboratory-confirmed COVID-19 exceeded 90% in clinical trials that included children and adolescents aged 5-11, 12-15, and 16-17 years (1-3). Limited real-world data on 2-dose mRNA vaccine effectiveness (VE) in persons aged 12-17 years (referred to as adolescents in this report) have al ...
    Supporting Files Public Domain
  • Disparities in COVID19 Vaccination Coverage Between Urban and Rural Counties US December 14 2020January 31 2022
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — U.S. December 14, 2020–January 31, 2022
    Saelee, Ryan ;
    Zell, Elizabeth
    3 04 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Higher COVID-19 incidence and Mortality rates in rural than in urban areas are well documented (1). These disparities persisted during the B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variants surges during late 2021 and early 2022 (1,2). Rural populations tend to be older (aged ≥65 years) and uninsured and are more likely to have underlying medical c ...
    Supporting Files Public Domain
  • Safety Monitoring of COVID19 Vaccine Booster Doses Among Persons Aged 1217 Years US December 9 2021February 20 2022
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — U.S. December 9, 2021–February 20, 2022
    Hause, Anne M. ;
    Baggs, James
    March 1, 2022  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Adults aged ≥18 years reported adverse reactions less frequently after receipt of a homologous Pfizer-BioNTech COVID-19 booster dose than after the second primary dose.What is added by this report? Among persons aged 12–17 years, reactions after Pfizer-BioNTech booster vaccination were generally mild to moder ...
    Supporting Files Public Domain
  • Effectiveness of COVID19 PfizerBioNTech BNT162b2 MRNA Vaccination in Preventing COVID19associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 517 Years VISION Network 10 States April 2021January 2022
    Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 MRNA Vaccination in Preventing COVID-19–associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
    Klein, Nicola P. ;
    Stockwell, Melissa S.
    March 1, 2022  | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    What is already known about this topic? Two doses of Pfizer-BioNTech vaccine provided protection against COVID-19 in persons aged 12–17 years during Delta predominance, but data during Omicron predominance and among children aged 5–11 years are lacking.What is added by this report? Two doses protect against COVID-19–associated emergency department ...
    Supporting Files Public Domain
  • Changes in Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID19 Pandemic United States January 2019January 2022
    Changes in Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Figure 2 SARSCoV2 B11529 Omicron Variant Transmission Within Households Four US Jurisdictions November 2021February 2022
    Supplementary Figure 2. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households – Four U.S. Jurisdictions, November 2021-February 2022
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Table Characteristics of persons with SARSCoV2 infection by receipt of followup SARSCoV2 antigen test to assess early termination of isolation YukonKuskokwim Delta region Alaska JanuaryFebruary 2022
    Supplementary Table: Characteristics of persons with SARS-CoV-2 infection by receipt of follow-up SARS-CoV-2 antigen test to assess early termination of isolation — Yukon-Kuskokwim Delta region, Alaska, January–February 2022
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Supplementary table for: Lefferts B, Blake I, Bruden D, et al. Antigen Test Positivity After COVID-19 Isolation — Yukon-Kuskokwim Delta Region, Alaska, January–February 2022. MMWR Morb Mortal Wkly Rep 2022;71:293–298.
    Public Domain
  • Pediatric Emergency Department Visits Before and During the COVID19 Pandemic United States January 2019January 2022
    Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic— United States, January 2019–January 2022
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Supplementary Figure 1 SARSCoV2 B11529 Omicron Variant Transmission Within Households Four US Jurisdictions November 2021February 2022
    Supplementary Figure 1. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households – Four U.S. Jurisdictions, November 2021-February 2022
    Centers for Disease Control and Prevention (U.S.)
    02/25/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    No Description
    Public Domain
  • Safety Monitoring of COVID19 Vaccine Booster Doses Among Adults US September 22 2021February 6 2022
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — U.S. September 22, 2021–February 6, 2022
    Hause, Anne M. ;
    Baggs, James
    2 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During September 22, 2021-February 6, 2022, approximately 82.6 million U.S. residents aged ≥18 years received a COVID-19 vaccine booster dose.* The Food and Drug Administration (FDA) has authorized a booster dose of either the same product administered for the primary series (homologous) or a booster dose that differs from the product administered ...
    Supporting Files Public Domain
  • Investigation of SARSCoV2 Transmission Associated With a Large Indoor Convention New York City NovemberDecember 2021
    Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention — New York City, November–December 2021
    Sami, Samira ;
    Horter, Libby
    2 18 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    During November 19-21, 2021, an indoor convention (event) in New York City (NYC), was attended by approximately 53,000 persons from 52 U.S. jurisdictions and 30 foreign countries. In-person registration for the event began on November 18, 2021. The venue was equipped with high efficiency particulate air (HEPA) filtration, and attendees were require ...
    Supporting Files Public Domain
941 - 960 / 9550
 Was this page helpful?
 Found an issue?
Send us an email at: publishinghd@cdc.gov